[HTML][HTML] An overview of SARS-COV-2 epidemiology, mutant variants, vaccines, and management strategies

T Farooqi, JA Malik, AH Mulla, T Al Hagbani… - Journal of Infection and …, 2021 - Elsevier
Background Over the last two decades, humanity has observed the extraordinary anomaly
caused by novel, weird coronavirus strains, such as severe acute respiratory syndrome …

[HTML][HTML] COVID-19: comprehensive review on mutations and current vaccines

AV Hebbani, S Pulakuntla, P Pannuru… - Archives of …, 2022 - Springer
Viral outbreaks had been a threat for the human race for a long time. Several epidemics and
pandemics have been reported in the past with serious consequences on human health and …

[HTML][HTML] A review of SARS-CoV-2 variants and vaccines: viral properties, mutations, vaccine efficacy, and safety

MA Islam - Infectious Medicine, 2023 - Elsevier
The severe acute respiratory syndrome coronavirus disease 2 instigated by coronavirus
disease of 2019 (COVID-19) has delivered an unfathomable obstruction that has touched all …

A comprehensive review of COVID-19 virology, vaccines, variants, and therapeutics

L Forchette, W Sebastian, T Liu - Current medical science, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of
the coronavirus disease 2019 (COVID-19), has caused more than 179 million infections and …

SARS-CoV-2: Current trends in emerging variants, pathogenesis, immune responses, potential therapeutic, and vaccine development strategies

A Salimi-Jeda, S Abbassi, A Mousavizadeh… - International …, 2021 - Elsevier
More than a year after the SARS-CoV-2 pandemic, the Coronavirus disease 19 (COVID-19)
is still a major global challenge for scientists to understand the different dimensions of …

[HTML][HTML] SARS-CoV-2 infection: new molecular, phylogenetic, and pathogenetic insights. Efficacy of current vaccines and the potential risk of variants

JC Rotondo, F Martini, M Maritati, C Mazziotta… - Viruses, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a newly discovered
coronavirus responsible for the coronavirus disease 2019 (COVID-19) pandemic. COVID-19 …

COVID‐19: An Overview of SARS‐CoV‐2 Variants—The Current Vaccines and Drug Development

N Bostanghadiri, P Ziaeefar, MG Mofrad… - BioMed Research …, 2023 - Wiley Online Library
The world is presently in crisis facing an outbreak of a health‐threatening microorganism
known as COVID‐19, responsible for causing uncommon viral pneumonia in humans. The …

[HTML][HTML] The end or a New Era of development of SARS-CoV-2 virus: Genetic variants responsible for severe COVID-19 and clinical efficacy of the most commonly …

D Miteva, M Kitanova, H Batselova, S Lazova… - Vaccines, 2023 - mdpi.com
Although the chief of the World Health Organization (WHO) has declared the end of the
coronavirus disease 2019 (COVID-19) as a global health emergency, the disease is still a …

[HTML][HTML] The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges

JA Malik, S Ahmed, A Mir, M Shinde, O Bender… - Journal of infection and …, 2022 - Elsevier
Abstract Background The SARS-CoV-2 coronavirus epidemic is hastening the discovery of
the most efficient vaccines. The development of cost-effective vaccines seems to be the only …

[HTML][HTML] Novel SARS-CoV-2 outbreak and COVID19 disease; a systemic review on the global pandemic

AH Al-Rohaimi, F Al Otaibi - Genes & Diseases, 2020 - Elsevier
Since the beginning of the 21st century, several viral outbreaks have threatened humankind
and posed a new challenge to the modern healthcare system. The recent outbreak in …